Advertisement

Topics

BIAL Company Profile

16:27 EST 17th November 2017 | BioPortfolio

In a time characterised by globalisation, the international dimension of Bial is playing an ever greater role in the group’s strategic objectives. Being part of the global market and responding to the needs of the people in an ever larger number of world regions is an essential part of Bial’s commitment to Society.
Bial is today an International Pharmaceutical Group. Our products are to be found in pharmacies in nearly 30 countries in 4 continents: Europe, America, Africa and Asia. Whether in Spain or in the Dominican Republic, Portugal or Mozambique, Cyprus, Senegal or Ecuador, the members of the Bial Group and its representatives always strive to serve and satisfy health professionals and the general public. Some of the group companies are: Laboratórios Bial, Medibial, Bialfar, Bialport, Bial Aristegui, Medimport and Medangol.

Contact

Phone: 351 22 986 6100
Fax: 351 22 986 6190
Email: info@bial.com


News Articles [11 Associated News Articles listed on BioPortfolio]

Neurocrine gains NA rights to Bial's Ongentys for Parkinson’s disease

Neurocrine Biosciences Inc. licensed exclusive North American development and commercialization rights to Bial-Portela & CA SA's Ongentys (opicapone), in Phase III in the US for Parkinson's disease (P...

Bial’s epilepsy drug shows clinical efficacy in real-life study

Bial and its licensee Eisai have reported positive real-life data of Zebinix (eslicarbazepine acetate) from the Euro-Esli study in patients with partial-onset seizures (POS).

Bial and Eisai report positive results from Phase II trial of Zebinix for epilepsy

Bial and Eisai have reported a positive outcome from a Phase II clinical trial (Study 208) of Zebinix (eslicarbazepine acetate) in children with focal-onset epilepsy.

Real-world data prove efficacy of Eisai and Bial's epilepsy treatment

Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset epilepsy in adults, as part of a post-market study of mor...

EC approves label expansion for Bial-Portela's epilepsy drug Zebinix

No harm to brain function from Zebinix/Aptiom, data shows

Portuguese pharma firm BIAL and Japan’s Eisai have announced data from a Phase II study which showed…

FRENCH CLINICAL TRIAL TRAGEDY - Dead for €1900

Precis A Phase I first in human clinical trial on healthy volunteers, sponsored by Portuguese pharmaceutical company Bial, went horribly wrong in early January 2016, leaving one volunteer dead and fiv...

Les données en vie réelle confirment l'efficacité clinique de Zebinix® (acétate ...

Bial et Eisai présentent aujourd'hui les données confirmant l'efficacité et la tolérance de Zebinix ® (acétate d'eslicarbazépine) dans la pratique clinique quotidienne, données qui viennent...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

The Bial 10-2474 Phase 1 Study-A Drug Development Perspective and Recommendations for Future First-in-Human Trials.

BIA 10-2474 (a fatty acid amide hydrolase inhibitor) was evaluated in a first-in-human phase 1 study in normal volunteers to assess safety/tolerability, pharmacokinetics, pharmacodynamics, and food ef...

A Novel Uncultured Bacterium of the Family Gallionellaceae: Description and Genome Reconstruction Based on the Metagenomic Analysis of Microbial Community in Acid Mine Drainage.

Drainage waters at the metal mining areas often have low pH and high content of dissolved metals due to oxidation of sulfide minerals. Extreme conditions limit microbial diversity in- such ecosystems....

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Bial and Eisai

Founded in 1924, Bial is an international pharmaceutical group with products available in over 30 countries throughout four continents. BIAL is the largest Portuguese pharmaceutical company and is...

BIAL

In a time characterised by globalisation, the international dimension of Bial is playing an ever greater role in the group’s strategic objectives. Being part of the global market and responding to t...

More Information about "BIAL" on BioPortfolio

We have published hundreds of BIAL news stories on BioPortfolio along with dozens of BIAL Clinical Trials and PubMed Articles about BIAL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIAL Companies in our database. You can also find out about relevant BIAL Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record